RECRUITING

Nutritional Supplementation in Geriatric Hip Fractures

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study is a randomized controlled trial comparing outcomes between geriatric hip fractures who received a commercially available (XR RecoveryTM, Salt Lake City Utah) peri-operative nutritional supplement for three weeks post-operatively to those who receive standard nutritional counseling. The main question it aims to answer is: - Does supplementation decrease muscle loss via ultrasound measurements of the cross-sectional area of the rectus femoris of the uninjured leg?

Official Title

Can Complex Carbohydrates and Essential Amino Acid Supplementation Improve Outcomes Following Geriatric Hip Fractures

Quick Facts

Study Start:2025-01-16
Study Completion:2027-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06773000

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Male or female, aged 65 years or older.
  2. 2. Presenting with a geriatric hip fracture (femoral neck, intertrochanteric, or subtrochanteric) requiring surgical intervention.
  3. 3. Able to provide informed consent.
  4. 4. Expected to survive at least 6 months after surgery, with no terminal illness.
  1. 1. Pre-existing conditions that significantly impair mobility prior to injury.
  2. 2. Severe renal or liver impairment.
  3. 3. Active treatment with investigational drugs or participation in another clinical trial within the last 30 days.
  4. 4. Inability to tolerate oral nutritional supplementation due to gastrointestinal disorders.
  5. 5. Allergies to any components of the nutritional supplement being tested.

Contacts and Locations

Study Contact

Abhishek Ganta, MD
CONTACT
(951) 492-8945
Abhishek.ganta@nyulangone.org

Principal Investigator

Abhishek Ganta, MD
PRINCIPAL_INVESTIGATOR
NYU Langone Health

Study Locations (Sites)

NYU Langone Health
New York, New York, 10016
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • Abhishek Ganta, MD, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-16
Study Completion Date2027-06-30

Study Record Updates

Study Start Date2025-01-16
Study Completion Date2027-06-30

Terms related to this study

Additional Relevant MeSH Terms

  • Geriatric Hip Fracture